CT-388
A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 Diabetes
Roche · Phase 3 · Recruiting · Enrollment 300
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.